Fiji vs Switzerland: Treatment success rate for patients treated for MDR-TB
Fiji
60.0%
in 2022
Switzerland
60.0%
in 2022
Fiji rank
120th
Switzerland rank
120th
Treatment success rate for patients treated for MDR-TB over time
- Fiji
- Switzerland
How they compare
Fiji currently reports 60.0% against 60.0% in Switzerland, a difference of 0.0%.
The two have swapped places 1 time across 6 shared years of data; in 2014 it was Fiji ahead.
Fiji ranks 120th and Switzerland ranks 120th of 163 countries.
Fiji has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Fiji | Switzerland | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 100.0% | 74.2% | 25.8% | Fiji |
| 2020s | 67.5% | 30.0% | 37.5% | Fiji |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Fiji or Switzerland?
- Fiji, at 60.0% against 60.0% in Switzerland as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Fiji and Switzerland?
- 0.0%, with Fiji ahead.
- How many years of comparable data are there for Fiji and Switzerland?
- 6 years are reported by both, from 2014 to 2022.
- How do Fiji and Switzerland rank globally for treatment success rate for patients treated for mdr-tb?
- Fiji ranks 120th and Switzerland ranks 120th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.